Reach Us +44-7480-724769

Journal of Addictive Behaviors,Therapy & RehabilitationISSN: 2324-9005

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Editorial, J Addict Behav Ther Rehabil Vol: 0 Issue: 0

Running Over the Same Old Ground: What�s Missing in Cocaine Clinical Pharmacotherapy Trials?

Jennifer G. Plebani*
University of Pennsylvania, USA
Corresponding author : Jennifer G. Plebani, PhD
Research Assistant Professor of Psychology in Psychiatry, University of Pennsylvania, 3900 Chestnut Street, Philadelphia, PA 19104, USA
Tel: +1-215-222-3200; Fax: +1- 215-386-5106
E-mail: [email protected]
Received: June 17, 2012 Accepted: June 19, 2012 Published: June 21, 2012
Citation: Melvin A (2012) Running Over the Same Old Ground: What’s Missing in Cocaine Clinical Pharmacotherapy Trials?. J Addict Behav Ther Rehabil 1:1. doi:10.4172/2324-9005.1000e102

Abstract

Running Over the Same Old Ground: What’s Missing in Cocaine Clinical Pharmacotherapy Trials?

In over two decades of cocaine treatment research, countless pharmacotherapies have been tested, without a single medication approved for the treatment of cocaine dependence. A short and entirely incomplete list of tested medications includes: olanzapine, valproate, coenzyme Q10, L-carnitine, cabergoline, reserpine, tiagabine, amantadine, propranolol, selegiline, modafinil, sertraline, disulfiram, baclofen, and citicoline. Setting aside the very real possibility that none of the medications tested to date is actually efficacious for treating cocaine dependence, there are three main issues that appear to have potentially hindered accurate findings in such studies.

Keywords:

Track Your Manuscript

Share This Page